Open Access
Volume 7, Number 3, September 2017
Article Number 17
Number of page(s) 5
Published online 25 August 2017
  1. Langtry HD, Markham A. Fluvastatin: a review of its use in lipid disorders. Drugs. 1999; 57: 583–606. [CrossRef] [PubMed] [Google Scholar]
  2. Scripture CD, Pieper JA. Clinical pharmacokinetics of fluvastatin. Clin Pharmacokinet. 2001; 40: 263–281. [CrossRef] [PubMed] [Google Scholar]
  3. Garnett WR. A review of current clinical findings with fluvastatin. Am J Cardiol. 1996; 78: 20–25. [CrossRef] [PubMed] [Google Scholar]
  4. Weiss RJ. Fluvastatin titrate-to-goal clinical practice study. Am J Ther. 1998; 5: 281–285. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  5. Tysk C, Al-Eryani AY, Shawabkeh AA. Acute pancreatitis induced by fluvastatin therapy. J Clin Gastroenterol. 2002; 35: 406–408. [CrossRef] [PubMed] [Google Scholar]
  6. eHealthMe study from FDA and social media reports. Review: could fluvastatin cause acute pancreatitis? [cited in 2016 April 10] [Google Scholar]
  7. Wilmink T, Frick TW. Drug-induced pancreatitis. Drug Saf. 1996; 14: 406–423. [CrossRef] [PubMed] [Google Scholar]
  8. Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol. 2005; 39: 709–716. [CrossRef] [PubMed] [Google Scholar]
  9. National Health Insurance Research Database, Taiwan. [cited in 2016 April 1, English version]. [Google Scholar]
  10. Lai SW, Liao KF, Liao CC, Muo CH, Liu CS, Sung FC. Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine (Baltimore). 2010; 89: 295–299. [CrossRef] [PubMed] [Google Scholar]
  11. Hung SC, Liao KF, Lai SW, Li CI, Chen WC. Risk factors associated with symptomatic cholelithiasis in Taiwan: a population-based study. BMC Gastroenterol. 2011; 11: 11–111. [CrossRef] [PubMed] [Google Scholar]
  12. Chen HY, Lai SW, Muo CH, Chen PC, Wang IJ. Ethambutol- induced optic neuropathy: a nationwide population-based study from Taiwan. Br J Ophthalmol. 2012; 96: 1368–1371. [CrossRef] [PubMed] [Google Scholar]
  13. Cheng KC, Chen YL, Lai SW, Mou CH, Tsai PY, Sung FC. Patients with chronic kidney disease are at an elevated risk of dementia: a population-based cohort study in Taiwan. BMC Nephrol. 2012; 13: 1471–2369. [CrossRef] [Google Scholar]
  14. Cheng KC, Chen YL, Lai SW, Tsai PY, Sung FC. Risk of esophagus cancer in diabetes mellitus: a population-based case-control study in Taiwan. BMC Gastroenterol. 2012; 12: 12–177. [CrossRef] [PubMed] [Google Scholar]
  15. Lai HC, Chang SN, Lin CC, Chen CC, Chou JW, Peng CY, et al. Does diabetes mellitus with or without gallstones increase the risk of gallbladder cancer? Results from a population-based cohort study. J Gastroenterol. 2013; 48: 856–865. [CrossRef] [PubMed] [Google Scholar]
  16. Lai HC, Tsai IJ, Chen PC, Muo CH, Chou JW, Peng CY, et al. Gallstones, a cholecystectomy, chronic pancreatitis, and the risk of subsequent pancreatic cancer in diabetic patients: a population-based cohort study. J Gastroenterol. 2013; 48: 721–727. [CrossRef] [PubMed] [Google Scholar]
  17. Chen YL, Cheng KC, Lai SW, Tsai IJ, Lin CC, Sung FC, et al. Diabetes and risk of subsequent gastric cancer: a population-based cohort study in Taiwan. Gastric Cancer. 2013; 16: 389–396. [CrossRef] [PubMed] [Google Scholar]
  18. Lai HC, Lin CC, Cheng KS, Kao JT, Chou JW, Peng CY, et al. Increased incidence of gastrointestinal cancers among patients with pyogenic liver abscess: a population-based cohort study. Gastroenterology. 2014; 146: 129–137. [CrossRef] [PubMed] [Google Scholar]
  19. Hung SC, Lai SW, Tsai PY, Chen PC, Wu HC, Lin WH, et al. Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk. Br J Cancer. 2013; 108: 1778–1783. [CrossRef] [PubMed] [Google Scholar]
  20. Yang SP, Muo CH, Wang IK, Chang YJ, Lai SW, Lee CW, et al. Risk of type 2 diabetes mellitus in female breast cancer patients treated with morphine: A retrospective population-based time-dependent cohort study. Diabetes Res Clin Pract. 2015; 110: 285–290. [CrossRef] [PubMed] [Google Scholar]
  21. Kuo SC, Lai SW, Hung HC, Muo CH, Hung SC, Liu LL, et al. Association between comorbidities and dementia in diabetes mellitus patients: population-based retrospective cohort study. J Diabetes Complications. 2015; 29: 1071–1076. [CrossRef] [PubMed] [Google Scholar]
  22. Lai SW, Muo CH, Liao KF, Sung FC, Chen PC. Risk of acute pancreatitis in type 2 diabetes and risk reduction on anti-diabetic drugs: a population-based cohort study in Taiwan. Am J Gastroenterol. 2011; 106: 1697–1704. [CrossRef] [Google Scholar]
  23. Liao KF, Lai SW, Li CI, Chen WC. Diabetes mellitus correlates with increased risk of pancreatic cancer: a population-based cohort study in Taiwan. J Gastroenterol Hepatol. 2012; 27: 709–713. [CrossRef] [PubMed] [Google Scholar]
  24. Hung SC, Hung SR, Lin CL, Lai SW, Hung HC. Use of celecoxib correlates with increased relative risk of acute pancreatitis: a case-control study in Taiwan. Am J Gastroenterol. 2015; 110: 1490–1496. [CrossRef] [Google Scholar]
  25. Liao K-F, Lin C-L, Lai S-W. Schizophrenia Correlates with Increased Risk of Hepatocellular Carcinoma in Men: A Cohort Study in Taiwan. International Medical Journal. 2015; 22. [Google Scholar]
  26. Lai SW, Lai HC, Lin CL, Liao KF. Finasteride use and acute pancreatitis in Taiwan. J Clin Pharmacol. 2015; 55: 657–660. [CrossRef] [PubMed] [Google Scholar]
  27. Shen ML, Liao KF, Tsai SM, Lin CL, Lai SW. Herpes zoster correlates with pyogenic liver abscesses in Taiwan. Biomedicine-Taiwan. 2016; 6: 24–29. [CrossRef] [Google Scholar]
  28. Cheng KC, Lin WY, Liu CS, Lin CC, Lai HC, Lai SW. Association of different types of liver disease with demographic and clinical factors. Biomedicine-Taiwan. 2016; 6: 16–22. [CrossRef] [Google Scholar]
  29. Liao K-F, Lin C-L, Lai S-W, Chen W-C. Parkinson’s disease and risk of pancreatic cancer: a population-based case-control study in Taiwan. Neurology Asia. 2015; 20. [Google Scholar]
  30. Lin HF, Lai SW, Lin WY, Liu CS, Lin CC, Chang CM. Prevalence and factors of elevated alanine aminotransferase in central Taiwan - a retrospective study. Biomedicine-Taiwan. 2016; 6: 25–30. [CrossRef] [Google Scholar]
  31. Smith HT, Jokubaitis LA, Troendle AJ, Hwang DS, Robinson WT. Pharmacokinetics of fluvastatin and specific drug interactions. Am J Hypertens. 1993; 6: 375S–382S. [CrossRef] [PubMed] [Google Scholar]
  32. Lai SW, Lin CL, Liao KF. Atorvastatin Use Associated With Acute Pancreatitis: A Case-Control Study in Taiwan. Medicine. 2016; 95: e2545. [CrossRef] [PubMed] [Google Scholar]
  33. Sica DA, Gehr TW. Rhabdomyolysis and statin therapy: relevance to the elderly. Am J Geriatr Cardiol. 2002; 11: 48–55. [CrossRef] [PubMed] [Google Scholar]
  34. Corsini A. The use of statins in optimising reduction of cardiovascular risk: focus on fluvastatin. Int J Clin Pract. 2004; 58: 494–503. [CrossRef] [PubMed] [Google Scholar]
  35. Neuvonen PJ, Backman JT, Niemi M. Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin. Clin Pharmacokinet. 2008; 47: 463–474. [CrossRef] [PubMed] [Google Scholar]
  36. Lai SW, Lin CL, Liao KF. Use of methimazole and risk of acute pancreatitis: A case-control study in Taiwan. Indian J Pharmacol. 2016; 48: 192–195. [CrossRef] [PubMed] [Google Scholar]
  37. Hung SC, Liao KF, Hung HC, Lin CL, Lai SW, Lin CH. Nabume- tone use and risk of acute pancreatitis in a case-control study. Pancreatology. 2016; 16: 353–357. [CrossRef] [PubMed] [Google Scholar]
  38. Liao KF, Cheng KC, Lin CL, Lai SW. Etodolac and the risk of acute pancreatitis. Biomedicine-Taiwan. 2017; 7: 25–29. [CrossRef] [EDP Sciences] [Google Scholar]
  39. Lai S-W, Lin H-F, Lin C-L, Liao K-F. No association between losartan use and acute pancreatitis in hypertensive patients. European Journal of Hospital Pharmacy. 2016; ejhpharm-2015-000840. [Google Scholar]